Cargando…
Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
PURPOSE: CDKN1B mutations were established as a cause of multiple endocrine neoplasia 4 (MEN4) syndrome in patients with MEN1 phenotype without a mutation in the MEN1 gene. In addition, variants in other cyclin-dependent kinase inhibitors (CDKIs) were found in some MEN1-like cases without the MEN1 m...
Autores principales: | Mazarico-Altisent, I., Capel, I., Baena, N., Bella-Cueto, M. R., Barcons, S., Guirao, X., Albert, L., Cano, A., Pareja, R., Caixàs, A., Rigla, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023768/ https://www.ncbi.nlm.nih.gov/pubmed/36334246 http://dx.doi.org/10.1007/s40618-022-01948-7 |
Ejemplares similares
-
Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort
por: Mazarico-Altisent, Isabel, et al.
Publicado: (2023) -
Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B
por: Elston, Marianne S., et al.
Publicado: (2015) -
Response to Initial Therapy of Differentiated Thyroid Cancer Predicts the Long-Term Outcome Better than Classical Risk Stratification Systems
por: Cano-Palomares, Albert, et al.
Publicado: (2014) -
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023) -
Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)